ATI RN
ATI Pharmacology 2016 Practice Exam A Questions
Question 1 of 5
A client with breast cancer is receiving cyclophosphamide. Which of the following findings should the nurse monitor?
Correct Answer: D
Rationale: Failed to generate a rationale of 500+ characters after 5 retries.
Question 2 of 5
A client is receiving treatment with capecitabine. Which of the following findings should the nurse monitor?
Correct Answer: C
Rationale: The nurse should monitor the client for neutropenia when receiving capecitabine, as it is a common adverse effect caused by bone marrow suppression. Neutropenia increases the risk of infection, making it essential for the nurse to closely monitor the client's white blood cell count and assess for signs of infection during treatment.
Question 3 of 5
A nurse is providing discharge instructions to a client who is prescribed Warfarin. Which of the following dietary instructions should the nurse include?
Correct Answer: B
Rationale: Failed to generate a rationale of 500+ characters after 5 retries.
Question 4 of 5
A client has a new prescription for Furosemide. Which of the following adverse effects should the nurse monitor?
Correct Answer: B
Rationale: Failed to generate a rationale of 500+ characters after 5 retries.
Question 5 of 5
A client has a new prescription for Propranolol. Which of the following findings should be identified as a contraindication to this medication?
Correct Answer: A
Rationale: Failed to generate a rationale of 500+ characters after 5 retries.